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Abstract 
Post-operative Acute Kidney Injury (AKI) is a common complication of surgery with 
significant short and long term adverse consequences. The adoption of diagnostic criteria for 
AKI (RIFLE, AKIN, KDIGO) has facilitated comparison of data reported by different centres, 
confirming that even mild AKI is associated with excess mortality.  It remains unclear 
whether this is caused by the kidney injury itself or whether AKI is simply a marker of 
underlying disease severity.  There is no trial evidence to support the use of any specific 
therapeutic intervention in post-operative AKI.  Best current treatment is therefore 
preventative by optimising hydration and avoidance of nephrotoxins, emphasising the 
importance of earlier detection and identification of individuals at high risk for AKI. In this 
review, we examine the latest literature on the management of post-operative AKI in adult 
patients, specifically the diagnosis and definition of AKI, epidemiology and pathogenesis and 
risk stratification in cardiac and non- cardiac surgery.  We also review the latest evidence on 
pharmacological and non- pharmacological interventions. 
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Diagnosis and Definition of post-operative AKI 
The lack of an agreed definition for acute kidney injury (AKI) has significantly limited the 
evidence base for AKI with increasing evidence that even mild, transient changes in serum 
creatinine are associated with significant adverse events. In 2004, the Acute Dialysis Quality 
Initiative (ADQI) group collaborated to create the Risk, Injury, Failure, Loss of kidney 
function, and End-stage kidney disease (RIFLE) criteria in order to attempt to address this 
issue (Table 1).  In 2007 the RIFLE criteria were modified to form the AKIN classification with 
the aim of increasing the sensitivity and specificity of AKI diagnosis. The AKIN classification 
includes a rise in creatinine of greater 26µmol/l and changes in creatinine over 48 hours 
rather than compared to a baseline value.  This definition has been further modified by the 
Kidney Disease Improving Global Outcomes (KDIGO) group and has been uniformly 
adopted to define AKI (Table 1)(1). Few observational studies have defined AKI using urine 
output criteria probably due to the fact that urine output outwith the intensive care setting is 
generally poorly measured. It has been shown, however, that urine output is a more 
sensitive measure than serum creatinine(2). This highlights the importance of accurate urine 
output measurements preoperatively particularly in patients deemed high risk for developing 
AKI. This would facilitate earlier detection of AKI prior to a rise in serum creatinine thereby 
preventing more severe renal injury. 
There are several limitations of a creatinine based definition for AKI and so focus has turned 
to developing more sensitive and specific biomarkers for AKI to allow earlier detection 
(Appendix). 
Incidence 
Post-operative AKI is a common complication of surgery. The incidence of post-operative 
AKI prior to 2004 was difficult to establish due to a lack of agreed definition. Incidence varies 
according to type of surgery with the majority of studies confined to cardiac surgery. Studies 
using the currently agreed definition for AKI in non -cardiac surgery are lacking with the main 
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ones summarised in Table 2. Using the KDIGO criteria, incidence of AKI was 11.8% ranging 
from 4.1% following Ear, Nose and Throat surgery to 13.2% after general surgery in a large 
cohort of over 16,000 United States Veterans (3). Results from a Scottish cohort of 12,482 
patients are comparable ranging from 4% following gynaecological surgery to 25% after 
vascular surgery also using the KDIGO criteria (4). A recent systematic review of 19 studies 
including 82, 514 patients undergoing major abdominal surgery reported a pooled incidence 
of AKI of 13.4 % (95 % CI 10.9-16.4 %)(5). 
Incidence of AKI following cardiac surgery is better reported. Results of a recent systematic 
review found an overall incidence of 25.8% in 35,021 patients undergoing cardiac 
surgeries(6). Incidence ranged from 12% to 43% when limited to studies using the RIFLE, 
AKIN or KDIGO criteria. A further larger systematic review of 91 studies encompassing 
320,086 patients undergoing cardiac surgery showed similar results with a pooled AKI 
incidence of 22.3% (95% CI 19.8 to 25.1) with 13.6%, 3.8% and 2.7% stage 1,2 and 3(7). 
Pathogenesis 
The aetiology of post-operative AKI is complex and not fully understood with numerous 
contributing factors. Renal hypoperfusion is an important and common aetiological factor in 
post-operative AKI.  Hypotension leads to a proinflammatory state with an increase in 
vasconstrictive mediators such as endothelin and angiotensin II leading to tubular ischaemia 
and injury. During major surgery renal hypotension has a number of aetiologies. These 
include hypovolaemia and reduced systemic vascular resistance caused by anaesthesia.  . 
Other contributing factors include perioperative use of nephrotoxins such as nonsteroidal 
anti-inflammatory drugs (NSAIDs), inhibitors of the renin angiotensin system and intravenous 
contrast media which is increasingly used during vascular surgery. Inhibitors of the renin 
angiotensin system lead to a reduction in angiotensin II and so in the presence of reduced 
renal blood flow peri-operatively; they cause a drop in GFR through loss of efferent arteriolar 
vasoconstriction. Ischaemia alone however cannot fully explain post-operative AKI with 
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inflammation playing an important role. Inflammation, sepsis and a systemic inflammatory 
response commonly occurs in the post-operative setting through the release of pro-
inflammatory cytokines and free radicals causing further renal injury.  One of the causes of 
AKI in cardiac surgery is related to use of cardiopulmonary bypass (CPB). Contact of blood 
products with the CPB surface and ischaemia reperfusion injury cause renal tubular damage 
through inducing a systemic inflammatory response(8). Choice of prophylactic antibiotics for 
surgery have also been shown to be an important contributing factor to post-operative AKI 
with flucloxacillin and gentamicin prophylaxis associated with increased rates of AKI(4).  
Risk Factors for post-operative AKI  
Awareness of the risk factors for AKI in patients undergoing surgery has a number of 
benefits. It allows for perioperative optimisation and closer monitoring of patients deemed 
high risk in the post-operative period. These measures may prevent AKI or prevent more 
severe AKI with significant long term implications. Risk stratification also allows the physician 
and patient to have an informed preoperative discussion about the likelihood of developing a 
complication and therefore the risks and benefits of the proposed surgery.  A number of risk 
factors for AKI in patients undergoing surgery have been identified: some of these relate to 
the patient and others to the surgical procedure (Table 2).  
Risk scores for AKI following Cardiac Surgery 
There are several risk scores in patients undergoing cardiac surgery, though not all have 
been externally validated.  The Cleveland Clinic Foundation score was developed in a cohort 
of 15, 838 patients to predict AKI requiring RRT (9). It is one of the most discriminative risk 
scores and has been validated in several other cohorts with area under receiving operating 
characteristic curves (AUCs) over 0.8(10, 11).  
The Society of Thoracic Surgeons (STS) bedside risk tool was developed in a cohort of 
449,524 patients and validated internally in 86,009 patients undergoing coronary artery 
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bypass graft (CABG) and/or valve surgery (c-statistic 0.83) (12). It has been subsequently 
validated in 2 Canadian cohorts and a cohort from the Mayo clinic (10, 11).  
The Simplified Renal Index (SRI) comprising of 8 variables was derived from a Canadian 
cohort of 10,571 patients undergoing cardiac surgery with CPB (11, 12). It has been 
validated in 2 Canadian cohorts of 2,566 and 6,814 patients both with an AUC 
0.78.  However, these tools all lack the ability to predict milder forms of AKI.  
The Multicentre Study of Perioperative Ischemia (MCSPI) Score event was developed in a 
cohort of 4,801 patients from 70 centres in 17 countries of patients undergoing coronary 
revascularization requiring the use of CPB (13) . AKI was defined as a postoperative serum 
creatinine of at least 177µmol/l accompanied by an increase of at least 62µmol/l from 
preoperative baseline, or AKI requiring dialysis. AUC was 0.84 in the derivation cohort and 
0.8 in the validation cohort. The disadvantage of this score was that it has not been 
externally validated. The 8 variables included comprise of both preoperative and 
intraoperative variables and so cannot be used as a preoperative risk score to stratify 
patients. 
A further risk score developed in 25,992 patients undergoing cardiac surgery from 2 UK 
centres and validated in 4,862 patients from a third centre predicted any stage of AKI with 
better or equivalent discrimination than 4 previously published scores. This score did not 
include intra or post-operative variables allowing its application pre-operatively(14). 
Risk scores for AKI following Non Cardiac Surgery 
There are fewer validated risk scores in patients undergoing non cardiac surgery. Kherterpal 
and colleagues examined post-operative AKI in 75 952 patients undergoing general surgery 
in the United States (15). Older age, male sex, emergency surgery, intraperitoneal surgery, 
diabetes mellitus necessitating oral therapy, diabetes mellitus necessitating insulin therapy, 
active congestive heart failure, ascites, hypertension, mild preoperative renal insufficiency, 
and moderate preoperative renal insufficiency were found to be independent risk factors for 
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post-operative AKI.  AKI was defined as a rise in serum creatinine of 177µmol/l or more from 
the preoperative value over the first 30 post-operative days with only 1% of their operations 
complicated by AKI.   A recent cohort examining patients undergoing orthopaedic surgery 
from the United Kingdom defined AKI using the KDIGO criteria which includes a rise of 
greater than 26µmol/l in serum creatinine therefore including milder forms of AKI. Predictors 
for AKI were sex, diabetes, number of prescribed drugs, lower estimated glomerular filtration 
rate, use of angiotensin converting enzyme inhibitors or angiotensin receptor blockers, and 
American Society of Anesthesiologists grade (ASA).  The development cohort comprised of 
6220 patients from two hospitals and externally validated in 4395 patients from a third 
hospital. The model’s predictive performance for discrimination was good (C statistic 0.74 in 
development cohort, 0.70 in validation cohort) (16). 
It is important to note that these epidemiological cohort studies lack urine output data which 
is a limits both early diagnosis and risk prediction. This however reflect clinical; practice in 
most hospital wards. 
Adverse outcomes following post-operative AKI 
Post-operative AKI is associated with adverse outcomes.   These include increased hospital 
length of stays, mortality and future risk of developing end stage renal disease (ESRD) and 
increase with increasing severity of AKI.   Even mild (Stage 1) AKI has been shown to be 
associated with adverse outcomes.   In a cohort of 161,185 US veterans undergoing major 
surgery, rates of hospital readmission within 30 days, in-hospital mortality, mortality within 90 
day and 1year as well as ESRD at 1 year were significantly higher in patients with AKI. This 
increased with increasing severity of AKI (3).  
A further large cohort of 51, 457 patient undergoing major surgery showed that patients with 
AKI had significantly higher cardiovascular mortality compared to those without (HR 1.95, 
95%CI 1.80 to 2.11) (17). Both these studies defined AKI using the KDIGO creatinine based 
criteria. In a cohort of over 10,000 patients undergoing orthopaedic from the United 
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Kingdom, survival was worse in patients with AKI compared with those without (adjusted 
hazard ratio 1.53, 95% confidence interval 1.38 to 1.70). Survival worsened with increasing 
severity of acute kidney injury but even mild acute kidney injury resulted in a considerably 
worse overall survival (adjusted hazard ratio 1.46, 1.30 to 1.63, P<0.001) (16).  
A recent meta-analysis examined the effects of AKI on mortality in patients undergoing 
cardiac surgeries(6). Despite recovery of renal function back to baseline before discharge, 
there was still an associated increase in long term mortality (HR 1.31 95%CI 1.16 to1.47, 
p<0.001) compared to those who did not develop AKI. This increased further in patients who 
did not recover their renal function back to baseline (HR 2.71 95%cI 1.26 to 5.82, p=0.01). 
However, caution must be applied to the interpretation of these studies due to their 
observational nature. 
Finally, there is evidence surrounding the economic implications of post-operative AKI with 
significantly higher hospital cost in patients who develop AKI (18).  
In view of these adverse effects of AKI, a working group of the 15thADQI conference have  
formulated consensus statement regarding minimal data elements and potential data 
sources necessary to trace the natural history of patients from onset of AKI to long-term 
outcome(19).  
Pharmacological and non-pharmacological interventions 
Diuretics 
Diuretics have been widely used both to prevent and treat AKI. It is thought that loop 
diuretics may decrease oxygen consumption thereby potentially reducing ischaemic injury 
and wash out necrotic debris preventing intratubular obstruction. However, clinical studies do 
not support this theory with prophylactic use of furosemide found to increase rates of AKI 
following cardiac surgery (20). Similarly, in a recent study of non-cardiac surgery, 
perioperative use of diuretics was associated with increased post-operative AKI (21). No 
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benefit was also shown in a Cochrane systematic review examining pharmacological 
interventions to prevent AKI (22). Their use is now only recommended in the context of fluid 
overload. 
Vasodilator Therapy 
The theory behind the use of vasodilator treatments such as dopamine, fenoldopam and 
atrial natriuretic peptide (ANP) is that they increase glomerular filtration rate through renal 
vasodilation and natriuresis. Dopamine was previously widely used in AKI but its use is now 
not recommended(1) . A large randomised controlled study and a Cochrane review have 
shown no benefit in patients with AKI (22, 23). These together with the possible adverse 
effect of even low dose dopamine have led to the current recommendation.  
Several small studies and meta-analyses have shown a beneficial effect of fenoldopam. 
However, a large multi-centre randomised controlled trial of patients undergoing cardiac 
surgery showed that in patients with AKI fenoldopam did not reduce the need for RRT or 30 
day mortality but was associated with increased hypotension(24). Its use is therefore also 
not currently recommended. 
Studies of ANP  have shown a potential benefit but these have been small and 
underpowered causing systemic hypotension and so its use is not routinely recommended 
(22). 
Other Pharmacological Interventions 
Several other pharmacological agents have been studied in the perioperative period. N-
acetylcysteine (NAC) is a potent antioxidant with vasodilatory effects as a result of increased 
nitric oxide availability. The use of NAC in cardiac surgery has been extensively examined 
with no benefit found (25). HMG Co reductase inhibitors (statins) have been studied in 
retrospective cohorts with conflicting results. A recent large randomised controlled trial of 
patients undergoing cardiac surgery, high dose perioperative atorvastatin did not reduce the 
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risk of post-operative AKI (26). Aspirin and clonidine have been examined in a randomised 
controlled trial of patients undergoing non-cardiac surgery. Neither reduced the risk of post-
operative AKI (27). 
Non-pharmacological Interventions 
The importance of achieving the balance of adequate resuscitation without causing fluid 
overload is becoming clear in the management of AKI(28).  
Maintaining renal perfusion through perioperative haemodynamic optimization is arguably 
the most effective means of preventing post-operative AKI. This is the use of perioperative 
monitoring and volume expansion through the use of fluid, blood transfusion  and inotropes 
to improve cardiac output and improve oxygen delivery  A meta-analysis of 20 studies 
showed that post-operative AKI was significantly reduced by perioperative haemodynamic 
optimisation compared with a control group (OR 0.64 95%CI 0.50 to 0.83, p<0.001)(29). A 
retrospective cohort study of 5,127 patients undergoing non-cardiac surgery found that risk 
of AKI was associated with intraoperative sustained periods of mean arterial pressure less 
than 60mm Hg (30). It would therefore follow that fluid therapy in the perioperative period 
may be an effective means of reducing AKI. However, a recent study examining the use of 
0.9% saline at a rate of 1.5 ml per kg per hour for 12 hours before major open abdominal 
surgery showed no reduction in rates of AKI (31). This lack of difference may have been due 
to the type of fluid used or the lack of a tailored regime based on volume assessment. It is 
also important to note that fluid overload can be detrimental leading to a reduction in GFR 
through increased subcapsular pressure and abdominal compartment syndrome (sustained 
intra-abdominal pressure greater than 20 mmHg with associated new organ dysfunction). 
Choice of intravenous fluids in the perioperative period remains controversial. The high 
chloride content of 0.9% saline has been shown to be associated with AKI compared with 
balanced solutions (32). More recently, randomised controlled trial comparing balanced 
crystalloid to 0.9% saline in the ICU setting showed no reduction in risk of AKI(33). Use of 
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hydroxyethyl starches (HES) are no longer recommended due to concerns regarding 
nephrotoxicity (34). 
While there are no randomised controlled trials to support avoidance of NSAIDs, 
aminoglycosides, inhibitors of the renin-angiotensin system and contrast media in the 
perioperative period there is certainly ample evidence that nephrotoxins can cause 
significant kidney injury in other settings. Minimising exposure to nephrotoxins would 
therefore seem a logical approach, particularly in high risk patients. 
Remote ischaemic preconditioning is thought to protect the kidney from subsequent injury 
through eliciting brief periods of ischaemia and reperfusion in distant tissues. This has 
recently been shown to reduce rates of AKI in a randomised controlled trial of 240 high risk 
patients undergoing cardiac surgery (35). However, other studies have shown no benefit (36, 
37).  It remains unclear whether general anaesthesia is associated with AKI compared with a 
combination of general anaesthesia and neuraxial anaesthesia with a meta-analysis 
suggesting reduced rates of AKI in the combined group but a large cohort study showing no 
difference(38, 39). 
Timing of the initiation of RRT for AKI remains controversial. Two recently published 
randomised controlled trials have shown conflicting result with the latter showing reduced 
ninety day mortality following early initiation (40, 41). 
In conclusion, post-operative AKI is common and associated with significant adverse events. 
It remains unclear whether these are caused by the kidney injury itself or whether AKI is 
simply a marker of underlying disease severity.   Awareness of the risk factors for AKI in 
patients undergoing surgery improves preoperative assessment and allows closer 
monitoring of patients deemed high risk in the post-operative period.  There is no evidence 
to support the use of pharmacological interventions perioperatively while haemodynamic 
optimization, avoidance of potential nephrotoxins and closer monitoring are all likely to 
prevent AKI.   Further prospective clinical studies are required. 
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Table 1: RIFLE, AKIN and KDIGO definitions for AKI 
Stage/Class Serum Creatinine or GFR Urine Output 
RIFLE 
(over 7 day window) 
Risk ↑ SCr × 1.5 or ↓ GFR >25% <0.5 mL/kg/h × 6 h 
Injury ↑ SCr × 2 or ↓ GFR >50% <0.5 mL/kg/h × 12 h 
Failure ↑ SCr × 3 or ↓ GFR >75% or 
SCr ≥ 353.6µmol/l with an 
acute rise of > 44.2 µmol/l 
<0.3 mL/kg/h × 24 h or 
anuria × 12 h 
Loss of kidney Function AKI requiring RRT >4 weeks  
ESKD RRT  dependent >3 month  
AKIN 
(over 48 hours) 
1 ↑ SCr ≥ 26.5 µmol/l or ↑SCr 
>=1.5 to 1.9 x baseline  
 
<0.5 mL/kg/h (>6 h) 
2 ↑ SCr >2 to 3 x baseline 
 
<0.5 mL/kg/h (>12 h) 
3 ↑ SCr >3 x baseline or SCr ≥ 
353.6 µmol/l with acute rise 
of ≥ 44.2 µmol/l or requiring 
RRT 
<0.3 mL/kg/h (24 h) or anuria 
(12 h) 
KDIGO 
1 ↑ SCr ≥ 26.5 µmol/l within 48 
hours or ↑SCr >1.5 to 1.9 x 
baseline over 7 days 
<0.5 mL/kg/h (>6 h) 
2 ↑ SCr >2 to 3 x baseline  
 
<0.5 mL/kg/h (>12 h) 
3 ↑ SCr >3 x baseline or SCr ≥ 
353.6 µmol/l with acute rise 
of ≥ 44.2µmol/l or initiation of 
RRT 
<0.3 mL/kg/h (24 h) or anuria 
(12 h) 
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Table 2: Incidence of AKI according to surgical specialty 
Author & Year Type of Surgery Definition for 
AKI 
Cohort 
Size 
Incidence 
Abdullah 2016(42) Bariatric Surgery KDIGO 1230 2.9% 
Cabezuelo 2006 
(43) 
Liver Transplant >50% of 
baseline 
184 30.9% 
Kimmel 2014 (44) Orthopaedic 
(Total joint arthroplasty) 
RIFLE 425 14.8% 
Grams 2015 (3) Overall 
Cardiac 
Ear Nose &Throat 
General 
Orthopaedic 
Thoracic 
Urology 
Vascular 
KDIGO 161185 
22179 
4741 
44597 
33564 
11779 
17704 
26621 
11.8% 
8.7% 
4.1% 
13.2% 
10.2% 
12% 
8.6% 
9.2% 
Bell 2015 (4) Orthopaedic 
Urology 
Vascular 
Gastroenterology 
Gynaecology 
KDIGO 7666 
823 
720 
3271 
403 
7-11% 
11.6-15.7% 
23.2-25.1% 
7.4%-12.2% 
4.0-4.5% 
Huber 2015 (45) Vascular KDIGO 3646 49% 
Vaught 2015 (46) Gynaecology RIFLE 2341 13% 
O’Connor (5) Major abdominal Surgery 
(systematic review of  19 
studies) 
RIFLE 
AKIN 
KDIGO 
82,514 13.4% 
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 Table 3: Risk Factors for Post-operative AKI 
Patient  Surgery 
Age Emergency Surgery 
Male Sex Cardiac surgery 
ASA grade Perioperative use of nephrotoxins 
(ACEI/ARB inhibitor/ 
NSAIDs/aminoglycosides) 
 
Chronic Kidney Disease 
 
Use of Intra-arterial Balloon Pump (IABP) 
Diabetes Use of CPB 
Liver disease Intraperitoneal Surgery 
Congestive Cardiac Failure Perioperative use of contrast media 
Hypertension  
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Appendix  
Biomarkers 
Serum creatinine does not rise until approximately 48 hours after the initial tubular insult and 
is affected by factors such as age, gender and muscle mass therefore focus has turned to 
developing more sensitive and specific biomarkers for AKI.  The optimum biomarker would 
detect tissue injury rather than functional damage correlating with severity as well as easy, 
cheap and quick to measure. This could potentially play an important future role in pre-
operative risk stratification allowing earlier detection of AKI and implementation of earlier 
interventions.  The search for biomarkers has led to a number of promising developments. 
The majority of these studies examine patients undergoing cardiac surgery. The 
Translational Research Investigating Biomarker Endpoints (TRIBE) Consortium has 
examined a number of biomarkers in cardiac surgery with the aim of improving pre-operative 
and post-operative risk stratification of AKI.  Promising biomarkers include urine interleukin-
18 (IL-18) and plasma neutrophil gelatinase associated lipocalin (NGAL) which have both 
been found to improve risk stratification (1, 2). Urinary kidney injury molecule-1 (KIM-1) has 
also found to show promise in early detection of AKI particularly in those undergoing cardiac 
surgery(3). A recent meta-analysis of 28 studies in adult patients undergoing cardiac surgery 
examining a number of biomarkers concluded that current biomarkers have generally poor 
and at best moderate discrimination for AKI when measured within the first 24 hours post 
cardiac surgery(4). Kashini et al performed a two stage multi-centre study in which they 
tested 340 proteins including previously described AKI biomarkers. They developed a panel 
of the top 2 performing biomarkers tissue inhibitor of metalloproteinase 2 and insulin-like 
growth factor binding protein 7 [TIMP-2]x[IGFBP7]  and validated their ability to predict 
moderate to severe AKI in 744 Intensive Care Unit (ICU) patients which included post 
cardiac surgery patients (Sapphire study)(5).This panel has also been tested in non-cardiac 
surgery with an area under receiving operating characteristic curve (AUC) for the risk of any 
AKI of 0.85, for early use of RRT 0.83 and 0.77 for 28-day mortality. The investigators found 
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that [TIMP-2]x[IGFBP7]  was the strongest predictor for AKI significantly improving the risk 
assessment(6). A further study examined this panel in high risk surgical patients. They found 
that a single urinary [TIMP2]x[IGFBP7] test accurately identified patients at risk for 
developing AKI within the ensuing 12 hours with an AUC of 0.84 (95% confidence interval, 
0.76-0.90; p < 0.0001)(7). 
Whilst these studies show promising results, biomarkers are not currently used routinely 
worldwide in post-operative patients. It is likely that it in the future a panel of biomarkers will 
be developed to facilitate earlier detection of AKI rather than an individual biomarker. 
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AKI Acute Kidney Injury 
RIFLE Risk, Injury, Failure, Loss of kidney function, and 
End-stage kidney disease 
AKIN Acute Kidney Injury Network 
KDIGO Kidney Disease Improving Global Outcomes 
RRT Renal replacement therapy 
NSAID Nonsteroidal anti-inflammatory drug 
CPB Cardiopulmonary bypass 
AUC Area under receiving operating characteristic 
curve 
ESRD End stage renal disease 
ANP Atrial natriuretic peptide 
NAC N-acetylcysteine 
HES Hydroxyethyl starches 
CABG Coronary artery bypass graft 
ASA American Society of Anesthesiologists 
TRIBE Translational Research Investigating Biomarker 
Endpoints 
NGAL Neutrophil gelatinase associated lipocalin 
[TIMP-2]x[IGFBP7]   Tissue inhibitor of metalloproteinase 2 and 
insulin-like growth factor binding protein 7 
 
by guest on O
ctober 19, 2016
D
ow
nloaded from
 
